硬脑膜动静脉瘘与Foix-Alajouanine综合征:功能评分评估及发病机制综述
该研究系统检索文献纳入18例硬脑膜动静脉瘘合并Foix-Alajouanine综合征患者,比较手术与栓塞两组功能评分,并构建Aminoff-Rankin复合评分(ARC)。结果显示两组功能评分或症状结局无显著差异;干预前ALS步态、mRS及ARC评分与症状改善相关,症状改善者干预后ALS步态、排尿及ARC评分平均低于未改善者。作者认为该类患者因急性脊髓病发作功能较差,若诊断和治疗得当可获得一定程度症状改善。
要点
- 纳入18例硬脑膜动静脉瘘合并Foix-Alajouanine综合征患者,11例(61.11%)仅手术,7例(38.89%)仅栓塞。
- 手术与栓塞两组功能评分或症状结局无显著差异。
- 干预前ALS步态、mRS及ARC评分与症状改善相关(rpb=0.43,P=0.04;rpb=0.47,P=0.02;rpb=0.48,P=0.04)。
核心结论
- 作者认为硬脑膜动静脉瘘合并Foix-Alajouanine综合征患者因急性脊髓病发作表现为更差的功能(功能评分更高),若诊断和治疗得当可获得一定程度症状改善,表现为干预后功能评分降低。
研究设计与样本
- 系统文献调查纳入18例患者,采用Aminoff-Logue量表(ALS)与改良Rankin量表(mRS)评分并组合为新型功能评分Aminoff-Rankin复合评分(ARC),比较手术与栓塞组功能评分,并行单侧点二列相关分析,同时综述硬脑膜动静脉瘘形成的发病机制。
主要发现
- 定量合成纳入18例患者,仅手术11例(61.11%),仅栓塞7例(38.89%)。
- 手术与栓塞两组功能评分或症状结局无显著差异。
- 干预前ALS步态、mRS及ARC评分与症状改善相关(rpb=0.43,P=0.04;rpb=0.47,P=0.02;rpb=0.48,P=0.04)。
- 症状改善者干预后ALS步态评分平均2.55 vs 未改善者4.43(P=0.02),排尿评分平均1.09 vs 2.71(P=0.01),ARC评分平均6.66 vs 11.57(P=0.01),改善者均低于未改善者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the use of functional scores in the evaluation of patients with dural arteriovenous fistula and Foix-Alajouanine syndrome. METHODS: We systematically surveyed the literature to identify relevant patients. Aminoff-Logue Scale (ALS) and modified Rankin Scale (mRS) scores were ascertained and combined to form a novel functional score, the Aminoff-Rankin Composite (ARC) score. We compared functional scores between surgery and embolization groups and ran one-sided point-biserial analyses to test our expectation that positive correlations exist between functional scores and treatment outcomes. Finally, we reviewed the pathogenesis of dural arteriovenous fistula formation. RESULTS: The quantitative synthesis included 18 patients. Surgery alone was performed in 11 patients (61.11%); 7 patients underwent embolization alone (38.89%). There were no significant differences in functional scores or symptom outcomes when we compared surgery to embolization. The pre-intervention ALS gait, mRS, and ARC scores were correlated with improved symptoms (rpb = 0.43, P = 0.04; rpb = 0.47, P = 0.02; rpb = 0.48, P = 0.04, respectively). In patients whose symptoms were improved, post-intervention ALS gait and micturition scores (2.55 vs. 4.43, P = 0.02 and 1.09 vs. 2.71, P = 0.01, respectively) and post-intervention ARC scores (6.66 vs. 11.57, P = 0.01) were on average lower than in patients whose symptoms were unimproved. CONCLUSIONS: We believe that patients with dAVF and Foix-Alajouanine syndrome present with worse function (higher functional scores) as a result of an acute myelopathic episode, and that if diagnosed and treated appropriately, will experience some level of symptom improvement that is evidenced by reduced post-intervention functional scores.
引用
- Lagman C, Chung LK, Chitale RV, et al. Dural Arteriovenous Fistula and Foix-Alajouanine Syndrome: Assessment of Functional Scores with Review of Pathogenesis. World Neurosurg. 2017. PMID: 28673891. doi:10.1016/j.wneu.2017.06.141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。